Accelerated Progression From Mild Cognitive Impairment to Dementia in People With Diabetes
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The effect of diabetes on mild cognitive impairment (MCI) and its conversion to dementia remains controversial. We sought to examine whether diabetes and pre-diabetes are associated with MCI and accelerate the progression from MCI to dementia. RESEARCH DESIGN AND METHODS: In the Kungsholmen Project, 963 cognitively intact participants and 302 subjects with MCI (120 with amnestic MCI [aMCI ] and 182 with other cognitive impairment no dementia [oCIND]) age ≥75 years were identified at baseline. The two cohorts were followed for 9 years to detect the incident MCI and dementia following international criteria. Diabetes was ascertained based on a medical examination, hypoglycemic medication use, and random blood glucose level ≥11.0 mmol/l. Pre-diabetes was defined as random blood glucose level of 7.8–11.0 mmol/l in diabetes-free participants. Data were analyzed using standard and time-dependent Cox proportional-hazards models. RESULTS: During the follow-up period, in the cognitively intact cohort, 182 people developed MCI (42 aMCI and 140 oCIND), and 212 developed dementia. In the MCI cohort, 155 subjects progressed to dementia, the multi-adjusted hazard ratio (95% CI) of dementia was 2.87 (1.30–6.34) for diabetes, and 4.96 (2.27–10.84) for pre-diabetes. In a Kaplan-Meier survival analysis, diabetes and pre-diabetes accelerated the progression from MCI to dementia by 3.18 years. Diabetes and pre-diabetes were neither cross-sectionally nor longitudinally associated with MCI. CONCLUSIONS: Diabetes and pre-diabetes substantially accelerate the progression from MCI to dementia, and anticipate dementia occurrence by more than 3 years in people with MCI. The association of diabetes with the development of MCI is less evident in old people.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dysfunction of multiple organ systems manifests similarly in diabetes as it does during normal chronological ageing, but in diabetes this frequently occurs at a younger age [2–4].”
From Cellular senescence: at the nexus between ageing and diabetes (2019) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · cited 1×
“ADRDA) criteria (34), and to the National Institute of Neurological Disorders”
BackgroundDiagnostic and Statistical Manual of Mental Disorders (3rd ed. rev.)
Drake, M. (1988) · The American Journal of Occupational Therapy · doi:10.5014/ajot.42.10.683b · Cited by 5,240
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946 · cited 1×
“Different criteria and subdivisions of MCI have been proposed and modified over time (12).”
BackgroundSelf-citationRomán, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781 · cited 3×
“This cohort included 120 aMCI subjects who had memory complaints and objective episodic memory impairment (14,24) and 182 oCIND subjects who had significant impairment in global cognitive performance, as defined in a previous report (15).”
BackgroundMethodSelf-citationGauthier, S., Reisberg, B., Zaudig, M., Petersen, R. C., Ritchie, K., Broich, K., Belleville, S., Brodaty, H., Bennett, D., Chertkow, H., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 3,850
Self-citation. Cerebral blood flow in dementia.
Hachinski, V. C., Iliff, L. D., Zilhka, E., Du Boulay, G. H., McAllister, V. L., Marshall, J., Russell, R. W. R., & Symon, L. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490510088009 · Cited by 3,186
Risk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187 · cited 2×
“Furthermore, many large population-based longitudinal studies have demonstrated an increased risk of dementia in people with diabetes (2), but the association of diabetes with Alzheimer’s disease is less evident in some studies (2,3).”
BackgroundMixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992
Increased Risk of Type 2 Diabetes in Alzheimer Disease
Janson, J., Laedtke, T., Parisi, J. E., O’Brien, P., Petersen, R. C., & Butler, P. C. (2004) · Diabetes · doi:10.2337/diabetes.53.2.474 · Cited by 950 · cited 1×
“Interestingly, a clinicopathologic study suggested that there may be a shared predisposition for developing amyloid in both the pancreas and the brain (40).”
Background
Research works printed but not linked: 3
- Nordic Council on Medicines, 1985, Guidelines for ATC Classification
- World Health Organization, 1999, Definition, Diabetes and Classification of Diabetes Mellitus and Its Complications
- Xu W . Diabetes mellitus and the risk of dementia: a population-based study. Karolinska Institutet. The frame of the thesis available at http://diss.kib.ki.se/2008/978–91-7357–516-4. Accessed 16 May 2008
Cited by
Mild cognitive impairment: a concept in evolution
Petersen, R. C., Caracciolo, B., Brayne, C., Gauthier, S., Jelic, V., & Fratiglioni, L. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12190 · Cited by 1,694
Self-citationClassification and Epidemiology of MCI
Roberts, R., & Knopman, D. S. (2013) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2013.07.003 · Cited by 839
Xue, M., Xu, W., Ou, Y.-N., Cao, X.-P., Tan, M.-S., Tan, L., & Yu, J.-T. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100944 · Cited by 715
Self-citationBiessels, G. J., Strachan, M. W. J., Visseren, F. L. J., Kappelle, L. J., & Whitmer, R. A. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70088-3 · Cited by 551
Diabetes and Cognitive Impairment
Zilliox, L. A., Chadrasekaran, K., Kwan, J. Y., & Russell, J. W. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0775-x · Cited by 539
Cooper, C., Sommerlad, A., Lyketsos, C. G., & Livingston, G. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14070878 · Cited by 570
Epidemiology of diabetes and diabetic complications in China
Ma, R. C. W. (2018) · Diabetologia · doi:10.1007/s00125-018-4557-7 · Cited by 491
“Diabetes is also associated with dementia and accelerates the progression from mild cognitive impairment to dementia by around 3 years [53].”
BackgroundWard, A., Tardiff, S., Dye, C., & Arrighi, H. M. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000354370 · Cited by 426
Cognitive function in patients with diabetes mellitus: guidance for daily care
Koekkoek, P. S., Kappelle, L. J., van den Berg, E., Rutten, G. E. H. M., & Biessels, G. J. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70249-2 · Cited by 393
Models and mechanisms of vascular dementia
Venkat, P., Chopp, M., & Chen, J. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.05.006 · Cited by 341
“Pre-diabetes and diabetes patients also risk a conversion of mild cognitive impairment into dementia [7].”
BackgroundCellular senescence: at the nexus between ageing and diabetes
Palmer, A. K., Gustafson, B., Kirkland, J. L., & Smith, U. (2019) · Diabetologia · doi:10.1007/s00125-019-4934-x · Cited by 337
Obesity Elicits Interleukin 1-Mediated Deficits in Hippocampal Synaptic Plasticity
Erion, J. R., Wosiski-Kuhn, M., Dey, A., Hao, S., Davis, C. L., Pollock, N. K., & Stranahan, A. M. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4200-13.2014 · Cited by 282
“This issue is especially pertinent in the context of an aging population because of the increased prevalence of cognitive decline with obesity and insulin resistance (Xu et al., 2010).”
BackgroundPal, K., Mukadam, N., Petersen, I., & Cooper, C. (2018) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-018-1581-3 · Cited by 276
Areosa Sastre, A., Vernooij, R. W., González-Colaço Harmand, M., & Martínez, G. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003804.pub2 · Cited by 272
Risk Factors for the Progression of Mild Cognitive Impairment to Dementia
Campbell, N. L., Unverzagt, F., LaMantia, M. A., Khan, B. A., & Boustani, M. A. (2013) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2013.07.009 · Cited by 288
The impact of diabetes on cognitive impairment and its progression to dementia
Dove, A., Shang, Y., Xu, W., Grande, G., Laukka, E. J., Fratiglioni, L., & Marseglia, A. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12482 · Cited by 252
Self-citationPasinetti, G. M., Wang, J., Ho, L., Zhao, W., & Dubner, L. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.006 · Cited by 239
Association of diabetes with amnestic and nonamnestic mild cognitive impairment
Roberts, R. O., Knopman, D. S., Geda, Y. E., Cha, R. H., Pankratz, V. S., Baertlein, L., Boeve, B. F., Tangalos, E. G., Ivnik, R. J., Mielke, M. M., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.01.001 · Cited by 203
Phenotypes of prediabetes and stratification of cardiometabolic risk
Stefan, N., Fritsche, A., Schick, F., & Häring, H.-U. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00082-6 · Cited by 208
Lima, J. E. B. F., Moreira, N. C. S., & Sakamoto-Hojo, E. T. (2022) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2021.503437 · Cited by 203
Stranahan, A. M., Hao, S., Dey, A., Yu, X., & Baban, B. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16642233 · Cited by 170
Voss, M. W., Carr, L. J., Clark, R., & Weng, T. (2014) · Mental health and physical activity · doi:10.1016/j.mhpa.2014.01.001 · Cited by 164
Impaired glycemia increases disease progression in mild cognitive impairment
Morris, J. K., Vidoni, E. D., Honea, R. A., & Burns, J. M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.033 · Cited by 157
Cardiometabolic multimorbidity and incident dementia: the Swedish twin registry
Dove, A., Guo, J., Marseglia, A., Fastbom, J., Vetrano, D. L., Fratiglioni, L., Pedersen, N. L., & Xu, W. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehac744 · Cited by 140
Self-citationAlagiakrishnan, K., Zhao, N., Mereu, L., Senior, P. A., & Senthilselvan, A. (2013) · BioMed Research International · doi:10.1155/2013/186106 · Cited by 145
“DM is associated with increased risk formild cognitive impairment (MCI) in themiddle-aged and elderly population [2, 3], but also seems to accelerate the progression of MCI to dementia in elderly people with DM [4].”
BackgroundMild cognitive impairment and quality of life in the oldest old: a closer look
Hussenoeder, F. S., Conrad, I., Röhr, S., Fuchs, Â., Pentzek, M., Bickel, H., Mösch, E., Weyerer, S. B., Werle, J., Wiese, B., et al. (2020) · Quality of Life Research · doi:10.1007/s11136-020-02425-5 · Cited by 143
Chang, S. S., Chen, S., McAvay, G., & Tinetti, M. E. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.04171.x · Cited by 148
Cognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline?
Kawamura, T., Umemura, T., & Hotta, N. (2012) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2012.00234.x · Cited by 130
Update on cognitive decline and dementia in elderly patients with diabetes
Bordier, L., Doucet, J., Boudet, J. M., & Bauduceau, B. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.02.002 · Cited by 136
Obesity-induced cognitive impairment in older adults: a microvascular perspective
Balasubramanian, P., Kiss, T., Tarantini, S., Nyúl-Tóth, Á., Ahire, C., Yabluchanskiy, A., Csipo, T., Lipecz, A., Tabak, A., Institoris, A., et al. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00736.2020 · Cited by 115
Visceral adipose NLRP3 impairs cognition in obesity via IL-1R1 on CX3CR1+ cells
Guo, D.-H., Yamamoto, M., Hernandez, C. M., Khodadadi, H., Baban, B., & Stranahan, A. M. (2020) · Journal of Clinical Investigation · doi:10.1172/jci126078 · Cited by 112
Bian, Z., Li, Q., Wang, L., Lu, C., Yin, S., & Li, X. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00011 · Cited by 120
“…impairment of glucose metabolism may increase the risk of cognitive impairment and accelerate the progress from MCI to dementia, and it is up to 80% of patients with AD (Ganguli et al., 2004; Busse et al., 2006; Yaffe et al., 2006; Hussain, 2007; Xu et al., 2010; Tuma, 2012; Roberts et al., 2014).”
BackgroundSpatial memory impairments in a prediabetic rat model
Soares, E. F. P., Prediger, R. D., Nunes, S., de Castro, A. A., Viana, S., Lemos, C., Souza, C. M. D. A., Agostinho, P. M., Cunha, R. A., Carvalho, E., et al. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.055 · Cited by 118
“In particular, a growing body of evidence indicates an increased risk of developing cognitive decline and dementia in a T2DM setting (Roriz-Filho et al., 2009; Xu et al., 2010; Ravona-Springer et al., 2012).”
BackgroundModels and mechanisms for hippocampal dysfunction in obesity and diabetes
Stranahan, A. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.04.045 · Cited by 103
Yamamoto, M., Guo, D.-H., Hernandez, C. M., & Stranahan, A. M. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.2506-18.2019 · Cited by 94
“Individuals with type 2 diabetes and obesity exhibit higher rates of cognitive impairment with aging in cross-sectional and longitudinal studies (Elias et al., 2005; Whitmer et al., 2008; Xu et al., 2010).”
BackgroundEarlier Age of Dementia Onset and Shorter Survival Times in Dementia Patients With Diabetes
Zilkens, R., Davis, W. A., Spilsbury, K., Semmens, J. B., & Bruce, D. G. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws387 · Cited by 89
Li, T., Fu, S., Huang, X., Zhang, X., Cui, Y., Zhang, Z., Ma, Y., Zhang, X., Yu, Q., Yang, S., et al. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.104988 · Cited by 92
Prevention of cognitive decline in ageing: dementia as the target, delayed onset as the goal
Fratiglioni, L., & Qiu, C. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70145-4 · Cited by 89
Self-citationCalvo‐Ochoa, E., & Arias, C. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2531 · Cited by 80
Ciudin, A., Espinosa, A., Simó‐Servat, O., Ruiz, A., Alegret, M., Hernández, C., Boada, M., & Simó, R. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.04.018 · Cited by 82
Wosiski-Kuhn, M., Erion, J. R., Gomez-Sanchez, E. P., Gomez-Sanchez, C. E., & Stranahan, A. M. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.01.020 · Cited by 75
“Individuals with type 2 diabetes, characterized by elevated fasting glucose and reduced insulin sensitivity, with progression to insulin insufficiency in the later stages of the disease, develop cognitive impairment earlier and at higher rates relative to individuals with normal glucose and insulin metabolism (Xu et a…”
How can elderly apolipoprotein E ε4 carriers remain free from dementia?
Ferrari, C., Xu, W., Wang, H., Winblad, B. G., Sorbi, S., Qiu, C., & Fratiglioni, L. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.03.003 · Cited by 90
“0 mmol/L in diabetes-free participants (Xu et al., 2010).”
Self-citationde Matos, A. M., de Macedo, M. P., & Rauter, A. P. (2018) · Medicinal Research Reviews · doi:10.1002/med.21440 · Cited by 66
Gut microbiota in dementia. Critical review of novel findings and their potential application
Łuc, M., Misiak, B., Pawłowski, M., Stańczykiewicz, B., Zabłocka, A., Szcześniak, D. M., Pałęga, A., & Rymaszewska, J. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110039 · Cited by 74
“It has been reported that these findings are statistically relevant for impaired fasting glycemia and insulin resistance (Ma et al., 2014; Monacelli et al., 2015; Morris et al., 2014; Xu et al., 2010).”
BackgroundZarrinkalam, E., Ranjbar, K., Salehi, I., Kheiripour, N., & Komaki, A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.138 · Cited by 74
Zhou, X., Zhang, J., Chen, Y., Ma, T., Wang, Y., Wang, J., & Zhang, Z. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-132354 · Cited by 64
Yang, W., Li, X., Pan, K., Yang, R., Song, R., Qi, X., Pedersen, N. L., & Xu, W. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12303 · Cited by 57
Self-citationFormaldehyde induces diabetes‐associated cognitive impairments
Tan, T., Zhang, Y., Luo, W., Lv, J., Han, C., Hamlin, J. N. R., Luo, H., Li, H., Wan, Y., Yang, X., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201701239r · Cited by 63
Yu, Y., Yan, L., Sun, Q., Hu, B., Zhang, J., Yang, Y., Dai, Y., Cui, W.-X., Xiu, S.-J., Hu, Y., et al. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.06.058 · Cited by 65
Glucocorticoid sensitization of microglia in a genetic mouse model of obesity and diabetes
Dey, A., Hao, S., Erion, J. R., Wosiski-Kuhn, M., & Stranahan, A. M. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.01.013 · Cited by 60
“, 2013) and longitudinal studies of cognition (Xu et al., 2010) have reliably demonstrated structural atrophy in the medial temporal lobe and behavioral impairment on tests of learning and memory in individuals with obesity and diabetes.”
BackgroundNursing home patients with diabetes: prevalence, drug treatment and glycemic control
Andreassen, L. M., Sandberg, S., Kristensen, G. B. B., Sølvik, U. Ø., & Kjome, R. L. S. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.04.012 · Cited by 60
Diabetes Mellitus, Cognitive Impairment, and Traditional Chinese Medicine
Seto, S. W., Yang, G., Kiat, H., Bensoussan, A., Kwan, Y. W., & Chang, D. (2015) · International Journal of Endocrinology · doi:10.1155/2015/810439 · Cited by 64
“Progression of MCI to dementia has been shown to be markedly accelerated by diabetes in elderly subjects who were either cognitively intact or diagnosedwithMCI at baseline [38].”
BackgroundAssociations between sleep duration and cognitive impairment in mild cognitive impairment
Basta, M., Simos, P. G., Vgontzas, A. N., Koutentaki, E., Tziraki, S., Zaganas, I. V., Panagiotakis, S. H., Kapetanaki, S., Fountoulakis, N., & Lionis, C. D. (2019) · Journal of Sleep Research · doi:10.1111/jsr.12864 · Cited by 64
Lietzau, G., Davidsson, W., Östenson, C., Chiazza, F., Nathanson, D., Pintana, H., Skogsberg, J., Klein, T., Nyström, T., Darsalia, V., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0517-1 · Cited by 62
Disturbed sleep and diabetes: A potential nexus of dementia risk
Holingue, C., Wennberg, A. M. V., Berger, S., Polotsky, V. Y., & Spira, A. P. (2018) · Metabolism · doi:10.1016/j.metabol.2018.01.021 · Cited by 60
Teng, Z., Feng, J., Dong, Y., Xu, J., Jiang, X. J., Chen, H.-F., Qi, Q., Li, R., Chen, W., & Lv, P. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.970122 · Cited by 59
“In particular, T2DM can accelerate the progression from mild cognitive impairment to dementia (2, 5).”
BackgroundMetabolic Reserve as a Determinant of Cognitive Aging
Stranahan, A. M., & Mattson, M. P. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110899 · Cited by 53
“Hippocampal shrinkage in stress-related an imbalance between excitatory and inhibitory neurotransmission is one potential mediator for this Even in the absence of drug treatment (which compromises metabolism independently of psychiatric disorders), diseases such as depression impair glycemic…”
The association of diabetes and dementia and possible implications for nondiabetic populations
Ravona‐Springer, R., & Beeri, M. S. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.152 · Cited by 57
Asslih, S., Damri, O., & Agam, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116138 · Cited by 54
Bruce, D. G., Davis, W. A., STARKSTEIN, S. E., & Davis, T. M. E. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132654 · Cited by 61
Ramlall, S., Chipps, J. A., Pillay, B., & Bhigjee, A. I. (2013) · African Journal of Psychiatry · doi:10.4314/ajpsy.v16i6.58 · Cited by 52
Meusel, L.-A., Kansal, N., Tchistiakova, E., Yuen, W., MacIntosh, B. J., Greenwood, C. E., & Anderson, N. D. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00148 · Cited by 52
“…et al., 2008; Frontiers in Aging Neuroscience www.frontiersin.org July 2014 | Volume 6 | Article 148 | 1 AGING NEUROSCIENCE Creavin et al., 2012; Crane et al., 2013; Roberts et al., 2014), and older individuals with T2DM progress to dementia at faster rates (Xu et al., 2010; Morris et al., 2014).”
BackgroundGao, Q., Gwee, X., Feng, L., Nyunt, M. S. Z., Feng, L., Collinson, S. L., Chong, M. S., Lim, W. S., Lee, T.-S. W., Yap, P. L. K., et al. (2018) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000488936 · Cited by 52
Diabetes–Alzheimer's Disease Link: Targeting Mitochondrial Dysfunction and Redox Imbalance
Carvalho, C., & Cardoso, S. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8056 · Cited by 50
“Also, a faster cognitive decline and a higher conversion rate of individuals who suffer from mild cognitive impairment (MCI) to dementia seem to occur in diabetic patients (193).”
Does Vascular Burden Contribute to the Progression of Mild Cognitive Impairment to Dementia?
Clerici, F., Caracciolo, B., Cova, I., Fusari Imperatori, S., Maggiore, L., Galimberti, D., Scarpini, E., Mariani, C., & Fratiglioni, L. (2012) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000343776 · Cited by 45
Self-citationZeng, K., Wang, Y., Ouyang, G., Bian, Z., Wang, L., & Li, X. (2015) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2015.00133 · Cited by 48
“…for Brain Research, Beijing Normal University, Beijing, China, 2Center for Collaboration and Innovation in Brain and Learning Sciences, Beijing Normal University, Beijing, China, 3Department of Vascular Neurosurgery, The Second Artillery General Hospital of PLA, Beijing, China, 4Department of…”
BackgroundInfluentialGlycemia, Diabetes Status, and Cognition in Hispanic Adults Aged 55–64 Years
Luchsinger, J. A., Cabral, R., Eimicke, J. P., Manly, J. J., & Teresi, J. A. (2015) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000208 · Cited by 48
“Moreover, persons with MCI and diabetes are more likely to advance to dementia (19,20).”
BackgroundAscher‐Svanum, H., Chen, Y.-F., Hake, A. M., Kahle‐Wrobleski, K., Schuster, D., Kendall, D. M., & Heine, R. J. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.01.002 · Cited by 47
Tracing temporal trends in dementia incidence over 25 years in central Stockholm, Sweden
Ding, M., Qiu, C., Rizzuto, D., Grande, G., & Fratiglioni, L. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12073 · Cited by 44
Self-citationThe factors contributing to cognitive dysfunction in type 2 diabetic patients
Xia, S.-S., Xia, W.-L., Huang, J., Zou, H., Tao, J., & Yang, Y. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2019.12.113 · Cited by 45
The Potential Roles of Artemisinin and Its Derivatives in the Treatment of Type 2 Diabetes Mellitus
Jiang, Y., Shui, J., Zhang, B., Chin, J.-W., & Yue, R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.585487 · Cited by 48
“It has been postulated that Alzheimer’s disease (AD) may represent the consequence of a distinct form of brain-specific IR and impaired glucose regulation (Xu et al., 2010; Akter et al., 2011; de la Monte, 2012; Shuba and Karan, 2012).”
BackgroundAlosco, M. L., & Gunstad, J. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0495-z · Cited by 47
GLP-1 and the Degenerating Brain: Exploring Mechanistic Insights and Therapeutic Potential
Moaket, O. S., Obaid, S. E., Obaid, F. E., Shakeeb, Y. A., Elsharief, S. M., Tania, A., Darwish, R., Butler, A. E., & Moin, A. S. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110743 · Cited by 46
Fujishima, M., Kawaguchi, A., Maikusa, N., Kuwano, R., Iwatsubo, T., Matsuda, H., (ADNI), F. T. J. A. D. N. I., & (J-ADNI), T. J. A. D. N. I. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160621 · Cited by 43
Liu, L., Wang, N., Kalionis, B., Xia, S., & He, Q. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577763 · Cited by 41
The association between diabetes and cognitive changes during aging
Papunen, S., Mustakallio-Könönen, A., AUVINEN, J. P., Timonen, M., Keinanen-Kiukaanniemi, S. M., & Sebert, S. P. (2020) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813432.2020.1802140 · Cited by 41
Antidiabetic therapies and Alzheimer disease
Bendlin, B. B. (2019) · Phlebolymphology · doi:10.31887/dcns.2019.21.1/bbendlin · Cited by 46
The role of autophagy in the treatment of type II diabetes and its complications: a review
Zhao, X., Bie, L., Pang, D.-R., Li, X., Yang, L., Chen, D., Wang, Y.-R., & Gao, Y. J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1228045 · Cited by 41
“Without effective intervention, diabetes will greatly accelerate the progression from mild cognitive impairment to dementia (182).”
BackgroundEndocrine Risk Factors for Cognitive Impairment
Moon, J. H. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.2.185 · Cited by 41
Zhang, H., Yang, X. H., Zhang, Y., Sheng, S., Zhang, L., Dong, Z., Gao, Q., Cai, W., Mou, Z., & Qi, J. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.07.105 · Cited by 39
Tomo, P. D., Alessio, N., Falone, S., Pietrangelo, L., Lanuti, P., Cordone, V., Santini, S. J., Pietrantonio, N. D., Marchisio, M., Protasi, F., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202002072rr · Cited by 37
Injurious falls before, during and after dementia diagnosis: a population-based study
Zhang, L., Wang, J., Dove, A. E., Yang, W., Qi, X., & Xu, W. (2022) · Age and Ageing · doi:10.1093/ageing/afac299 · Cited by 36
Self-citationAccelerated Progression from Mild Cognitive Impairment to Dementia Among APOE ε4ε4 Carriers
Xu, W., Caracciolo, B., Wang, H., Santoni, G., Winblad, B. G., & Fratiglioni, L. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121369 · Cited by 38
“Medical conditions, including ischemic heart disease, heart failure, or left ventricular failure or other myocardial insufficiency, atrial fibrillation, stroke, hypertension, diabetes and prediabetes, were ascertained based on the information from the inpatient register and medical examinations as described in detail…”
Self-citationDiabetes and the link between neuroplasticity and glutamate in the aging human motor cortex
Fried, P. J., Pascual‐Leone, Á., & Bolo, N. R. (2019) · Clinical Neurophysiology · doi:10.1016/j.clinph.2019.04.721 · Cited by 36
Diabetes and Prediabetes Inhibit Reversion from Mild Cognitive Impairment to Normal Cognition
Makino, K., Lee, S., Bae, S., Chiba, I., Harada, K., Katayama, O., Shinkai, Y., Makizako, H., & Shimada, H. (2021) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2021.02.033 · Cited by 33
Liu, J., Yang, X., Li, Y., Xu, H., Ren, J., & Zhou, P. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.847218 · Cited by 35
“…risk factor of developing certain mental disorders, including cognitive dysfunction, dementia, and depression (Biessels and Despa, 2018; van Sloten and Schram, 2018; Xue et al., 2019), and older individuals with T2DM progress to dementia at faster rates (Xu et al., 2010; Morris et al., 2014).”
BackgroundGlimepiride attenuates Aβ production via suppressing BACE1 activity in cortical neurons
Liu, F., Wang, Y., Yan, M., Zhang, L., Pang, T., & Liao, H. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.10.052 · Cited by 34
Cognitive functioning among patients with diabetic foot
Marseglia, A., Xu, W., Rizzuto, D., Ferrari, C., Whisstock, C., Brocco, E., Fratiglioni, L., Crepaldi, G., & Maggi, S. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.07.005 · Cited by 36
“…vascular dementia and Alzheimer's disease (Biessels, Staekenborg, Brunner, Brayne, & Scheltens, 2006) and that diabetes may accelerate progression frommild cognitive impairment to dementia (Xu et al., 2010). foot; DFP-CoDe, Diabetic Foot al Working Group on Diabetic ial Making Test part A; TMT–”
BackgroundSelf-citationNutritional supplementation for Alzheimerʼs disease?
Shea, T. B., & Remington, R. (2015) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000138 · Cited by 37
Progress of Diabetic Severity and Risk of Dementia
Chiu, W., Ho, W., Liao, D., Lin, M., Chiu, C., Su, Y., & Chen, P. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1677 · Cited by 35
“Patients in a prediabetic (33, 34) or an early stage (1, 32) of diabetes have a higher risk of cognitive impairment.”
Wang, R., Fratiglioni, L., Liang, Y., Welmer, A., Xu, W., Mangialasche, F., Johnell, K., & Qiu, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119582 · Cited by 32
Self-citationThe therapeutic potential of probucol and probucol analogues in neurodegenerative diseases
Sharif, A., Mamo, J. C. L., Lam, V., Al‐Salami, H., Mooranian, A., Watts, G. F., Clarnette, R., Luna, G., & Takechi, R. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00398-w · Cited by 32
“Numerous cross-sectional and longitudinal studies have unequivocally shown that the prevalence of dementia among patients with T2D significantly surpasses that of age-matched non-diabetics [92–94].”
Zhu, W., Zhang, H., Niu, T., Liu, K., Farooqui, H. F. M., Sun, R., Chen, X., Yuan, Y., & Wang, S. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.03.051 · Cited by 33
Ehrlich, J. R., Swenor, B. K., Zhou, Y., & Langa, K. M. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab157 · Cited by 32
Prajjwal, P., Marsool, M. D. M., Inban, P., Sharma, B., Asharaf, S., Aleti, S., Gadam, S., Sakini, A. S. A., & Hadi, D. D. (2023) · Disease-a-Month · doi:10.1016/j.disamonth.2023.101557 · Cited by 32
Type 2 Diabetes Interacts With Alzheimer Disease Risk Factors to Predict Functional Decline
Thomas, K. R., Bangen, K. J., Weigand, A. J., Edmonds, E. C., Sundermann, E. E., Wong, C. G., Eppig, J. S., Werhane, M. L., Delano‐Wood, L., & Bondi, M. W. (2019) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000332 · Cited by 31
Dong, W., Bian, Z., Li, Q., Wang, L., Lu, C., & Li, X. (2015) · Clinical Neurophysiology · doi:10.1016/j.clinph.2015.05.016 · Cited by 30
“The T2DM may be associated with increased risk of aMCI (Ganguli et al., 2004; Busse et al., 2006; Yaffe et al., 2006; Fischer et al., 2007; Luchsinger et al., 2007; Toro et al., 2009; Shimada et al., 2010; Xu et al., 2010; Strachan et al., 2011; Tuma, 2012; Roberts et al., 2014; Bian et al., 2014; Zhang et al., 2014).”
BackgroundDecision-making in primary onset middle-age type 2 diabetes mellitus: a BOLD-fMRI study
Sun, D., Ma, Y., Sun, Z., Xie, L., Huang, J., Chen, W.-S., Duan, S., Lin, Z., Guo, R.-W., Le, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10228-x · Cited by 34
“brain atrophy, white matter hyperintensity, cerebral infarcts or cerebral microbleeds); (3) any other types of systemic diseases impairing cognitive functioning; (4) a history of neurological or psychiatric disease; (5) a history of clinically diagnosed stroke or severe, uncontrolled cardiovascular disease; (6) a hist…”
Self-citationButler, L. M., Houghton, R., Abraham, A., Vassilaki, M. E., & Durán-Pacheco, G. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.749305 · Cited by 29
Katsel, P., Roussos, P., Beeri, M. S., Gama-Sosa, M. A., Gandy, S., Khan, S., & Haroutunian, V. H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206547 · Cited by 29
Metadata
- Authors
- Xu, W., Caracciolo, B., Wang, H.-X., Winblad, B., Bäckman, L., Qiu, C., & Fratiglioni, L.
- Affiliations
- Stockholm University (SE)
- Corresponding author
- Xu, Weili
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2010-08-16
- Volume
- 59
- Issue
- 11
- Pages
- 2928-2935
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2963552
- OpenAlex
- W2138030160
- Cited by
- 260
- References
- 47
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 21 · 2023: 18 · 2022: 14 · 2021: 22 · 2020: 19 · 2019: 18 · 2018: 14 · 2017: 13 · 2016: 9 · 2015: 15 · 2014: 26 · 2013: 20 · 2012: 13
- FWCI
- 8.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Forskningsrådet för Arbetsliv och Socialvetenskap
- Karolinska Institutet
- Vetenskapsrådet
- Swedish Brain Power
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- prediabetes, mild cognitive impairment, dementia, conversion to dementia, amnestic mild cognitive impairment, older adults, incident dementia
- MeSH terms
- Aged, Aged, 80 and over, Amnesia, Cognition Disorders, Cross-Sectional Studies, Dementia, Diabetes Mellitus, Educational Status, Female, Follow-Up Studies, Humans, Male, Prediabetic State, Severity of Illness Index, Incidence, Disease Progression, Risk Assessment, Stroke, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

